Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Adolor completes reacquisition of all rights to alvimopan

Sep. 7, 2011

Evotec and Roche enter worldwide agreement for EVT-302

Sep. 6, 2011

AMT and NIH sign exclusive license agreement for AAV-5-based gene therapy vectors

Sep. 6, 2011

Astellas Pharma and Evec sign license agreement

Sep. 6, 2011

Addex Pharmaceuticals regains rights to metabotropic glutamate mGlu4 receptor PAM program

Sep. 5, 2011

Royal DSM and Sinochem establish global joint venture

Sep. 5, 2011

PTC Therapeutics and Genzyme restructure collaboration agreement for ataluren

Sep. 5, 2011

AnaptysBio completes generation of therapeutic antibodies for partner

Sep. 2, 2011

Synageva and Mitsubishi Tanabe Pharma sign research and development partnership

Sep. 2, 2011

Chugai in-licenses Japanese rights to two monoclonal antibodies

Sep. 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...